MarketInOut Stock Screener Log In | Sign Up
 

Novocure Ltd

NASDAQ • Healthcare • Medical Devices • Quote as of 09/11/2026
Novocure Ltd stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization1,806.07 mln
Float86.13 mln
Earnings Date10/22/2026

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-3.13
Reliable

Relative Strength

10 / 100
Significantly lagging

Debt / Equity

0.69
Moderate leverage

Pre-Tax Margin

-22%
Deeply loss-making

ROE

-43.69
Deeply negative

Business Description

NovoCure is a medical company focused on fighting cancer through a technology called Tumor Treating Fields, which uses electrical fields to slow or stop the growth of solid tumors. The company sells several devices under the Optune brand name and is actively running clinical trials across a range of cancer types, including lung, brain, pancreatic, and ovarian cancer. Founded in 2000 and based in Switzerland, NovoCure operates across the United States, Europe, Japan, and Greater China.

Key Fundamentals

EPS-1.30
ROE-43.69
RPS6.16
ROIC-38.67
ROA-14.87
Interest Cover-64.36
EBITDA, mln-103
EV / EBITDA-18.05
EV / EBIT-15.60
Revenue, mln699
EV / Revenue2.67

Financial Strength

Altman Z-Score1.19
Piotroski F-Score 4 / 9
Beneish M-Score-3.13
Price to Intrinsic Value20.03
Short Ratio8.44
Short % of Float12.53

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -12.07% 7 / 100   
1 Month -11.82% 17 / 100   
2 Months -13.79% 22 / 100   
6 Months 29.14% 86 / 100   
1 Year 27.03% 79 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us